Validation of a telephone questionnaire for Parkinson's disease.
about
Molecular markers of early Parkinson's disease based on gene expression in bloodHigh-resolution whole-genome association study of Parkinson disease.Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson diseaseSelf-reported parkinsonian symptoms in the EPIC-Norfolk cohort.Prevalence and associated comorbidities of restless legs syndrome (RLS): Data from a large population-based door-to-door survey on 19176 adults in Tehran, Iran.Association of fibrinogen with Parkinson disease in elderly Japanese-American men: a prospective studyNovelty seeking and introversion do not predict the long-term risk of Parkinson diseaseA rare novel deletion of the tyrosine hydroxylase gene in Parkinson disease.The population-based Occupational and Environmental Health Prospective Cohort Study (AMIGO) in The Netherlands.Alpha-synuclein, alcohol use disorders, and Parkinson disease: a case-control studyAnxious personality predicts an increased risk of Parkinson's diseaseDesign and validity of a clinic-based case-control study on the molecular epidemiology of lymphomaVitamin D from different sources is inversely associated with Parkinson disease.Screening questionnaires for parkinsonism: a systematic reviewBeta-synuclein gene variants and Parkinson's disease: a preliminary case-control study.Coffee, caffeine-related genes, and Parkinson's disease: a case-control studyAccuracy and sensitivity of Parkinsonian disorder diagnoses in two Swedish national health registers.Can a screening questionnaire accurately identify mild Parkinsonian signs?Variants in estrogen-related genes and risk of Parkinson's diseaseDo interactions between SNCA, MAPT, and LRRK2 genes contribute to Parkinson's disease susceptibility?Common variants in PARK loci and related genes and Parkinson's disease.Environmental and occupational risk factors for progressive supranuclear palsy: Case-control study.A door-to-door survey to estimate the prevalence of Parkinsonism in PakistanComplete ascertainment of Parkinson disease in the Swedish Twin Registry.C9ORF72 intermediate repeat copies are a significant risk factor for Parkinson disease.A Swedish family with de novo alpha-synuclein A53T mutation: evidence for early cortical dysfunction.Relationship between uric acid levels and progressive supranuclear palsy.Alpha-synuclein in gastric and colonic mucosa in Parkinson's disease: Limited role as a biomarker.Ser(P)-1292 LRRK2 in urinary exosomes is elevated in idiopathic Parkinson's disease.Limb-kinetic apraxia affects activities of daily living in Parkinson's disease: a multi-center study.Field validation of a method for population screening of parkinsonism.Parkinson's disease biomarkers: perspective from the NINDS Parkinson's Disease Biomarkers Program.Prevalence of Parkinson's disease in Cantalejo, Spain: a door-to-door survey.Lifetime exposure to estrogen and progressive supranuclear palsy: Environmental and Genetic PSP study.Traumatic Brain Injury and Firearm Use and Risk of Progressive Supranuclear Palsy Among Veterans.Relation of Enteric α-Synuclein to Gastrointestinal Dysfunction in Patients With Parkinson's Disease and in Neurologically Intact Subjects
P2860
Q24292810-D766CF4C-A705-4D03-BB06-F5E8957546BCQ24535861-0106C6D9-7D5D-4596-8BC5-9D1A986D00DDQ24596763-60C07C20-8C82-453A-AE42-B575B61147AEQ24813512-19738C82-BBE2-4948-AE39-45F252317BB5Q31163061-61E7144C-A524-4810-B5B6-98C24F1E0F2CQ33637422-BCBEFF40-78DE-4B18-947F-3713B795A234Q34054945-48E5AF3A-AA7A-472B-8CB8-BA894AB80B91Q34511443-5DED88B7-9B02-4B02-A36B-E9C090BD70C4Q34589277-4706B023-9E07-4C59-A8AF-77719EA3D4B1Q34670663-BE563CFE-ACC7-4F52-864B-9B742ADD99A0Q34951991-BFFAE010-D347-42B6-84A9-D12A1606ACCBQ35031964-64D96454-3561-4C1B-BA3C-485847AD9A92Q35327512-5DDE399F-CDB7-4260-B740-B7DA15125A72Q35659470-F4D8A0ED-D228-4409-96B6-75C7A236970EQ35994987-32CF8C22-632C-4361-83E1-A8C8D6B2191FQ36011013-81654414-7A66-4673-8C21-9F1A7818B67BQ36031919-90AFEA76-49EB-4C5F-879C-4BBBF36FA01FQ36443271-7A2FE140-AC96-4783-9AF5-8520DF67CCAFQ36491681-AB9EE7F8-4161-445D-B50A-C992018E02B2Q36491685-4E3DD1D8-893F-4CAC-A8AD-787DCF800500Q36711910-48F8B17B-F101-45C2-8B4B-4CB1AE843611Q36885365-AEEFE0E8-1F4C-4C0A-952D-AE717E3AADF6Q37042462-A680FE78-9931-4B9A-BD98-CCE7C21C7EC7Q37142973-9A1564BF-9C22-48BA-A592-A924869E5121Q37273743-2EF08175-9D6A-499E-A165-5D5380585378Q37438098-65DC02D6-229C-4719-A3C9-DB8967BFE6B4Q37601192-84C78205-BEB0-40CF-BBDF-E7499B98E9BFQ38930110-15D78D19-1ACA-4DE9-9930-1F0CE7E8178FQ39686532-15F4F2D9-B6FF-4DEE-AEA9-FE1E916E144EQ41475885-D9B5E9E9-B877-4DBE-94C9-09AA467A547FQ43478170-50C92E9A-BD33-4333-9BA2-9477F5B30369Q47338262-1324FDAA-B156-4B30-99DE-BD5B7866688EQ47576591-167885A8-4EC6-4E2D-91CC-A1EBA2275C7EQ49817768-DC3063A9-972D-4AFD-B1A4-3067A0CE4828Q55415545-01A4870A-7996-4595-A836-D3C33ABE8B81Q57174175-AFF9EA93-8554-44D6-BB24-DAACA8F47627
P2860
Validation of a telephone questionnaire for Parkinson's disease.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Validation of a telephone questionnaire for Parkinson's disease.
@en
Validation of a telephone questionnaire for Parkinson's disease.
@nl
type
label
Validation of a telephone questionnaire for Parkinson's disease.
@en
Validation of a telephone questionnaire for Parkinson's disease.
@nl
altLabel
Validation of a Telephone Questionnaire for Parkinson’s Disease
@en
prefLabel
Validation of a telephone questionnaire for Parkinson's disease.
@en
Validation of a telephone questionnaire for Parkinson's disease.
@nl
P2093
P1476
Validation of a telephone questionnaire for Parkinson's disease
@en
P2093
D J Schaid
D M Maraganore
P304
P356
10.1016/S0895-4356(98)00017-1
P577
1998-06-01T00:00:00Z